Medtronic plc is a leading global medical technology enterprise that invents develops manufactures and distributes an extensive range of devicebased medical therapies These solutions serve healthcare systems clinicians physicians and patients across the world The companys operations are categorized into several key portfolios Cardiovascular Portfolio This segment focuses on cardiac health providing technologies for heart rhythm management including implantable pacemakers defibrillators and monitoring systems alongside cardiac ablation tools and remote patient software It also addresses structural heart issues with products like aortic and pulmonary valves surgical repair devices and endovascular stent grafts in addition to offerings for percutaneous coronary interventions eg angioplasty balloons Medical Surgical Portfolio Offering a broad spectrum of surgical instruments and therapies this division includes staples vessel sealing devices wound closure products and electrosurgical equipment It also pioneers surgical artificial intelligence and roboticassisted platforms alongside solutions for hernia repair gynecology lung conditions minimally invasive gastrointestinal and hepatologic diagnostics patient monitoring airway management ventilation therapies and renal disease Neuroscience Portfolio This division delivers specialized products for a diverse group of medical professionals such as spinal surgeons neurosurgeons neurologists pain management specialists and ENT experts Its offerings span energy surgical instruments advanced imageguided and intraoperative imaging systems robotic guidance for spine procedures and therapies targeting the brains vasculature Diabetes Operating Unit Dedicated to diabetes management this unit provides innovative solutions like insulin pumps and their associated consumables continuous glucose monitoring CGM systems and smart insulin pen technologies Established in 1949 Medtronic plc maintains its corporate headquarters in Dublin Ireland
Financial Ratios (TTM)
Gross Margin
65.02%
Operating Margin
17.78%
Net Margin
13.20%
ROA
5.16%
Price to Book
2.06
Price to Sales
2.80
Valoramos tu privacidad
Usamos cookies para analizar el tráfico y mostrar anuncios. Acepta todas las cookies o continúa solo con las esenciales. Más información